Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Novartis Investigative Site, Wels

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Lübeck

Novartis Investigative Site, Greensboro

Novartis Investigative Site, Greer

Novartis Investigative Site, Toulouse

Novartis Investigative Site, Jacksonville

Novartis Investigative Site, West Palm Beach

Novartis Investigative Site, Essen

Novartis Investigative Site, Mainz

Novartis Investigative Site, Frankfurt

Novartis Investigative Site, St Louis

Novartis Investigative Site, Rouen

Novartis Investigative Site, Boston

Novartis Investigative Site, Graz

Novartis Investigative Site, Vienna

Novartis Investigative Site, Barrie

Novartis Investigative Site, Waterloo

Novartis Investigative Site, Montreal

Novartis Investigative Site, Mangalore

Novartis Investigative Site, Nagpur

Novartis Investigative Site, Nashik

Novartis Investigative Site, Kisarazu

Novartis Investigative Site, Hachiōji

Novartis Investigative Site, Minato-ku

Novartis Investigative Site, Shinjuku-ku

Novartis Investigative Site, Košice